<i>Clostridioides difficile</i> infection in coronavirus disease 2019: an underestimated problem?

• DOI: 10.20452/pamw.15715
• Publication Date: 2020-12-14T15:15:27Z
• Authors: Konrad Lewandowski; Mariusz Rosołowski; Magdalena Kaniewska; Piotr Kucha; Anna Meler; Waldemar Wierzba; Grażyna Rydzewska
• Keywords: Pandemic; Coronavirus; Clostridioides

ARTICLE Clostridioides difficile infection in COVID -19 121 transcription-polymerase chain reaction test.The treatment of is mainly symptomatic and based on international research guidelines. 7,8Recommended drugs include chloroquine, hydroxychloroquine, azithromycin, lopinavir / ritonavir. 9The use tocilizumab remdesivir can be considered severely ill patients. 10,11As the rates bacterial coinfections are high, empiric antibiotic therapy often necessary. 7It has been estimated that over INTROduCTION On March 11, 2020, World Health Organization announced a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS -CoV -2). 1-3The most common symptoms disease 2019 (COVID -19) SARS -2 fever (83%-99%), cough (59%-82%), fatigue (44%-70%), diarrhea (2%-50%). 2,4-6The diagnosis established detecting RNA reverse